Immunization with glutathione S-transferase and mutant toxic shock syndrome toxin 1 fusion protein protects against Staphylococcus aureus infection

FEMS Immunology and Medical Microbiology

Volumn 45, Issue 1, 2005, Pages 45-51

  Cui, Jing Chun ^a,b   Hu, Dong Liang ^a   Lin, Yan Chun ^c   Qian, Ai Dong ^c   Nakane, Akio ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b DALIAN NATIONALITIES UNIVERSITY   (China)

^c JILIN AGRICULTURAL UNIVERSITY   (China)

Author keywords

Fusion protein; Infection; Staphylococcus aureus; Toxic shock syndrome toxin; Vaccine

Indexed keywords

ALUMINUM POTASSIUM SULFATE; GAMMA INTERFERON; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; IMMUNOLOGICAL ADJUVANT; NEUTRALIZING ANTIBODY; TOXIC SHOCK SYNDROME TOXIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL COUNT; BLOOD SAMPLING; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG PURIFICATION; IMMUNIZATION; INFECTION PREVENTION; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SPLEEN CELL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SURVIVAL RATE; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL TOXINS; BACTERIAL VACCINES; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; ENTEROTOXINS; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN G; INTERFERON TYPE II; LYMPHOCYTES; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; RECOMBINANT FUSION PROTEINS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA; VACCINES, SYNTHETIC;

EID: 20544470842     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsim.2005.01.010     Document Type: Article

References (51)

1. G.L. Archer Staphylococcus aureus: a well-armed pathogen Clin. Infect. Dis. 26 1998 1179 1181
2. H. Miles, W. Lesser, and P. Sears The economic implications of bioengineered mastitis control J. Dairy Sci. 75 1992 596 605
3. J.R. Fitzgerald, S.R. Monday, T.J. Foster, G.A. Bohach, P.J. Hartigan, W.J. Meaney, and C.J. Smyth Characterization of a putative pathogenicity island from bovine Staphylococcus aureus encoding multiple superantigens J. Bacteriol. 183 2001 63 70
4. K. Kenny, R.F. Reiser, F.D. Bastida-Corcuera, and N.L. Norcross Production of enterotoxins and toxic shock syndrome toxin by bovine mammary isolates of Staphylococcus aureus J. Clin. Microbiol. 31 1993 706 707
5. H. Etz, D.B. Minh, T. Henics, A. Dryla, B. Winkler, C. Triska, A.P. Boyd, J. Sollner, W. Schmidt, U. von Ahsen, M. Buschle, S.R. Gill, J. Kolonay, H. Khalak, C.M. Fraser, A. von Gabain, E. Nagy, and A. Meinke Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus Proc. Natl. Acad. Sci. USA 99 2002 6573 6578
6. D. McKenney, K.L. Pouliot, Y. Wang, V. Murthy, M. Ulrich, G. Doring, J.C. Lee, D.A. Goldmann, and G.B. Pier Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen Science 284 1999 1523 1527
7. C. Michie Staphylococcal vaccines Trends Immunol. 23 2002 461 463
8. M.M. Dinges, P.M. Orwin, and P.M. Schlievert Exotoxins of Staphylococcus aureus Clin. Microbiol. Rev. 13 2000 16 34
9. J.K. Rasheed, R.J. Arko, J.C. Feeley, F.W. Chandler, C. Thornsberry, R.J. Gibson, M.L. Cohenm, C.D. Jeffriesm, and C.V. Broome Acquired ability of Staphylococcus aureus to produce toxic shock-associated protein and resulting illness in a rabbit model Infect. Immun. 47 1985 598 604
10. S. Jarraud, C. Mougel, J. Thioulouse, G. Lina, H. Meugnier, F. Forey, X. Nesme, J. Etienne, and F. Vandenesch Relationships between Staphylococcus aureus genetic background, virulence factors, agar groups (alleles), and human disease Infect. Immun. 70 2002 631 641
11. M.C. Booth, L.M. Pence, P. Mahasreshti, M.C. Callegan, and M.S. Gilmore Clonal associations among Staphylococcus aureus isolates from various sites of infection Infect. Immun. 69 2001 345 352
12. J.M. Musser, P.M. Schlievert, A.W. Chow, P. Ewan, B.N. Kreiswirth, V.T. Rosdahl, A.S. Naidu, W. Witte, and R.K. Selander A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome Proc. Natl. Acad. Sci. USA 87 1990 225 229
13. P.M. Schlievert Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses J. Allergy Clin. Immunol. 108 2001 S107 S110
14. P. Marrack, and J. Kappler The staphylococcal enterotoxins and their relatives Science 248 1990 705 711
15. C. Jupin, S. Anderson, C. Damais, J.E. Alouf, and M. Parant Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon J. Exp. Med. 167 1988 752 761
16. W.W. Kum, K.B. Laupland, R.H. See, and A.W. Chow Improved purification and biologic activities of staphylococcal toxic shock syndrome toxin 1 J. Clin. Microbiol. 31 1993 2654 2660
17. G.A. Bohach, D.J. Fast, R.D. Nelson, and P.M. Schlievert Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses Crit. Rev. Microbiol. 17 1990 251 272
18. K.C. Kain, M. Schulzer, and A.W. Chow Clinical spectrum of nonmenstrual toxic shock syndrome (TSS): comparison with menstrual TSS by multivariate discriminant analyses Clin. Infect. Dis. 16 1993 100 106
19. B.L. Kotzin, D.Y. Leung, J. Kappler, and P. Marrack Superantigens and their potential role in human disease Adv. Immunol. 54 1993 99 166
20. B.A. Crass, and M.S. Bergdoll Involvement of staphylococcal enterotoxins in nonmenstrual toxic shock syndrome J. Clin. Microbiol. 23 1986 1138 1139
21. V.T. Lee, A.H. Chang, and A.W. Chow Detection of staphylococcal enterotoxin B among toxic shock syndrome (TSS)- and non-TSS-associated Staphylococcus aureus isolates J. Infect. Dis. 166 1992 911 915
22. R.G. Ulrich, M.A. Olson, and S. Bavari Development of engineered vaccines effective against structurally related bacterial superantigens Vaccine 16 1998 1857 1864
23. S. Bavari, B. Dyas, and R.G. Ulrich Superantigen vaccines: a comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin A J. Infect. Dis. 174 1996 338 345
24. R.J. Neill, M. Jett, R. Crane, J. Wootres, C. Welch, D. Hoover, and P. Gemski Mitogenic activities of amino acid substitution mutants of staphylococcal enterotoxin B in human and mouse lymphocyte cultures Infect. Immun. 64 1996 3007 3015
25. M.A. Woody, T. Krakauer, R.G. Ulrich, and B.G. Stiles Differential immune responses to staphylococcal enterotoxin B mutations in a hydrophobic loop dominating the interface with major histocompatibility complex class II receptors J. Infect. Dis. 177 1998 1013 1022
26. C.M. Cullen, L.R. Blanco, P.F. Bonventre, and E. Choi A toxic shock syndrome toxin 1 mutant that defines a functional site critical for T-cell activation Infect. Immun. 63 1995 2141 2146
27. P.F. Bonventre, H. Heeg, C.K. Edwards, and C.M. Cullen A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity Infect. Immun. 63 1995 509 515
28. J.M. Hurley, R. Shimonkevitz, A. Hanagan, K. Enney, E. Boen, S. Malmstrom, B.L. Kotzin, and M. Matsumura Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1 J. Exp. Med. 181 1995 2229 2235
29. P.F. Bonventre, H. Heeg, C. Cullen, and C.J. Lian Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome Infect. Immun. 61 1993 793 799
30. D.L. Murray, C.A. Earhart, D.T. Mitchell, D.H. Ohlendorf, R.P. Novick, and P.M. Schlievert Localization of biologically important regions on toxic shock syndrome toxin 1 Infect. Immun. 64 1996 371 374
31. G.H. Lowell, C. Colleton, D. Frost, R.W. Kaminski, M. Hughes, J. Hatch, C. Hooper, J. Estep, L. Pitt, M. Topper, R.E. Hunt, W. Baker, and W.B. Baze Immunogenicity and efficacy against lethal aerosol staphylococcal enterotoxin B challenge in monkeys by intramuscular and respiratory delivery of proteosome-toxoid vaccines Infect. Immun. 64 1996 4686 4693
32. G.H. Lowell, R.W. Kaminski, S. Grate, R.E. Hunt, C. Charney, S. Zimmer, and C. Colleton Intranasal and intramuscular proteosome-staphylococcal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxication in mice Infect. Immun. 64 1996 1706 1713
33. M.A. Woody, T. Krakauer, and B.G. Stiles Staphylococcal enterotoxin B mutants (N23K and F44S): biological effects and vaccine potential in a mouse model Vaccine 15 1997 133 139
34. A. Nakane, M. Okamoto, M. Asano, M. Kohanawa, and T. Minagawa Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice Infect. Immun. 63 1995 1165 1172
35. D.L. Hu, K. Omoe, S. Sasaki, H. Sashinami, H. Sakuraba, Y. Yokomizo, K. Shinagawa, and A. Nakane Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection J. Infect. Dis. 188 2003 743 752
36. R. Robbins, S. Gould, and M. Bergdoll Detecting the enterotoxigenicity of Staphylococcus aureus strains Appl. Microbiol. 28 1974 946 950
37. B.G. Stiles, T. Krakauer, and P.F. Bonventre Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model Infect. Immun. 63 1995 1229 1234
38. R.C. Bone Gram-positive organisms and sepsis Arch. Intern. Med. 154 1994 26 34
39. J.C. Lee The prospects for developing a vaccine against Staphylococcus aureus Trends Microbiol. 4 1996 162 166
40. D.P. Greenberg, J.I. Ward, and A.S. Bayer Influence of Staphylococcus aureus antibody on experimental endocarditis in rabbits Infect. Immun. 55 1987 3030 3034
41. I.M. Nilsson, J.M. Patti, T. Bremell, M. Hook, and A. Tarkowski Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death J. Clin. Invest. 101 1998 2640 2649
42. J.K. McCormick, H. Hirt, G.M. Dunny, and P.M. Schlievert Pathogenic mechanisms of enterococcal endocarditis Curr. Infect. Dis. Rep. 2 2000 315 321
43. P.M. Schlievert, L.M. Jablonski, M. Roggiani, I. Sadler, S. Callantine, D.T. Mitchell, D.H. Ohlendorf, and G.A. Bohach Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals Infect. Immun. 68 2000 3630 3634
44. J. Gampfer, V. Thon, H. Gulle, H.M. Wolf, and M.M. Eibl Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome Vaccine 20 2002 1354 1364
45. B.G. Stiles, A.R. Garza, R.G. Ulrich, and J.W. Boles Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model Infect. Immun. 69 2001 2031 2036
46. I.M. Nilsson, M. Verdrengh, R.G. Ulrich, S. Bavari, and A. Tarkowski Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity J. Infect. Dis. 180 1999 1370 1373
47. R.D. LeClaire, R.E. Hunt, and S. Bavari Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination Infect. Immun. 70 2002 2278 2281
48. R.F. Meyer, L. Miller, R.W. Bennett, and J.D. MacMillan Development of a monoclonal antibody capable of interacting with five serotypes of Staphylococcus aureus enterotoxin Appl. Environ. Microbiol. 47 1984 283 287
49. G.A. Bohach, C.J. Hovde, J.P. Handley, and P.M. Schlievert Cross-neutralization of staphylococcal and streptococcal pyrogenic toxins by monoclonal and polyclonal antibodies Infect. Immun. 56 1988 400 404
50. S. Bavari, R.G. Ulrich, and R.D. LeClaire Cross-reactive antibodies prevent the lethal effects of Staphylococcus aureus superantigens J. Infect. Dis. 180 1999 1365 1369
51. W.W. Kum, and A.W. Chow Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1 J. Infect. Dis. 183 2001 1739 1748